Shanghai Vital Deeptech revenue and financials
In the fiscal year ended December 2025, Shanghai Vital Deeptech reported revenue of ¥1.85B (+218.50% year over year). The net loss was ¥126.6M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +218.50%
- 2025 vs 2024
- Net margin
- -6.8%
- 2024: 18.5%
How Shanghai Vital Deeptech is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 17.0% a year on average over the last 3 years
Compound annual growth rate: from ¥1.16B in 2022 to ¥1.85B in 2025.
Profitable in 4 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 1,852 | 581 | 965 | 1,158 | 880 |
| Cost of revenue | 1,511 | 357 | 534 | 531 | 385 |
| Gross profit | 341 | 225 | 430 | 627 | 495 |
| Selling, general and administrative | 360 | 260 | 217 | 173 | 159 |
| Research and development | 227 | 184 | 163 | 108 | 45.6 |
| Operating income | -272 | -253 | -8.6 | 258 | 222 |
| EBIT | -272 | -253 | -8.6 | 258 | 222 |
| EBITDA | -207 | -192 | 22.9 | 286 | 247 |
| Interest expense | 57.7 | 19.3 | 14.0 | 4.6 | 2.4 |
| Pre-tax income | -232 | 39.6 | 169 | 514 | 497 |
| Income tax | 0.9 | 46.1 | 85.3 | 127 | 120 |
| Net income | -127 | 108 | 151 | 424 | 377 |
| Net income to common shareholders | -127 | 108 | 151 | 424 | 377 |
| Basic EPS | -0.14 | 0.12 | 0.16 | 0.46 | 0.41 |
| Diluted EPS | -0.14 | 0.12 | 0.16 | 0.46 | 0.41 |
| Average shares (basic) | 911 | 917 | 931 | 931 | 911 |
| Average shares (diluted) | 911 | 917 | 931 | 931 | 911 |
| Dividend per share | — | 0.04 | 0.05 | 0.14 | 0.12 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 612 | 535 | 783 | 370 | 507 | 192 | 274 | 107 | 102 | 99.1 | 203 | 373 |
| Cost of revenue | 482 | 436 | 722 | 281 | 385 | 123 | 231 | 44.3 | 58.3 | 22.5 | 177 | 158 |
| Gross profit | 130 | 99.0 | 60.8 | 88.8 | 121 | 69.9 | 42.4 | 62.3 | 43.5 | 76.6 | 26.2 | 214 |
| Selling, general and administrative | 4.4 | 102 | 101 | 104 | 89.5 | 65.8 | 70.5 | 65.1 | 57.4 | 67.1 | 50.9 | 70.8 |
| Research and development | 173 | 56.8 | 122 | 25.2 | 38.8 | 40.5 | 62.6 | 45.9 | 59.2 | 16.8 | 45.2 | 64.1 |
| Operating income | -171 | -67.9 | -204 | -12.8 | -9.1 | -39.9 | -109 | -52.6 | -79.7 | -11.8 | -57.5 | 28.3 |
| EBIT | 273 | -67.9 | -204 | -12.8 | -9.1 | -39.9 | -109 | -52.6 | -79.7 | -11.8 | -57.5 | 28.3 |
| EBITDA | 273 | -51.7 | -188 | 1.8 | 6.2 | -24.8 | -93.8 | -44.7 | -67.5 | -3.9 | -49.6 | 35.5 |
| Interest expense | 20.1 | 11.0 | 13.7 | 19.6 | 19.3 | 5.2 | 7.9 | 9.2 | 4.2 | 3.0 | 6.7 | — |
| Pre-tax income | 253 | -72.5 | -195 | -43.6 | 61.1 | -54.6 | 161 | 16.1 | -102 | -36.0 | -49.7 | 47.4 |
| Income tax | 54.8 | -24.8 | -23.4 | -0.6 | 37.2 | -12.4 | 56.1 | 7.6 | -17.4 | -0.1 | -26.5 | 30.6 |
| Net income | 227 | -16.9 | -145 | -22.1 | 61.3 | -20.5 | 139 | 39.1 | -54.2 | -16.6 | -12.5 | 45.0 |
| Net income to common shareholders | 227 | -16.9 | -145 | -22.1 | 61.3 | -20.5 | 139 | 39.1 | -54.2 | -16.6 | -12.5 | 45.0 |
| Basic EPS | — | -0.02 | -0.16 | -0.02 | 0.07 | -0.02 | 0.15 | 0.04 | -0.06 | -0.02 | -0.01 | 0.05 |
| Diluted EPS | — | -0.02 | -0.16 | -0.02 | 0.07 | -0.02 | 0.15 | 0.04 | -0.06 | -0.02 | -0.01 | 0.05 |
| Average shares (basic) | — | 909 | 911 | 910 | 911 | 910 | 936 | 908 | 899 | 924 | 931 | 930 |
| Average shares (diluted) | — | 909 | 911 | 910 | 911 | 910 | 936 | 908 | 899 | 924 | 931 | 930 |
| Dividend per share | — | — | — | — | — | — | 0.04 | — | — | — | 0.05 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 11,823 | 9,997 | 10,586 | 9,762 | 9,167 |
| Current assets | 7,700 | 5,388 | 5,175 | 5,450 | 5,622 |
| Cash and equivalents | 1,596 | 2,988 | 3,049 | 2,744 | 2,796 |
| Short-term investments | 46.2 | 694 | 681 | 1,333 | — |
| Receivables | 653 | 148 | 170 | 77.5 | 515 |
| Inventory | 4,528 | 1,393 | 1,103 | 900 | 706 |
| Net property, plant and equipment | 1,208 | 990 | 566 | 222 | 72.3 |
| Goodwill | 214 | 214 | 214 | 214 | 214 |
| Other intangible assets | 87.5 | 97.3 | 110 | 125 | 122 |
| Long-term investments | 2,053 | 2,892 | 3,354 | 3,072 | 2,589 |
| Current liabilities | 2,721 | 744 | 1,009 | 828 | 1,091 |
| Accounts payable | 994 | 269 | 300 | 174 | 164 |
| Long-term debt | 361 | 252 | 245 | 15.0 | — |
| Total debt | 1,706 | 426 | 669 | 259 | — |
| Total liabilities | 3,352 | 1,293 | 1,779 | 1,377 | 1,536 |
| Total equity (incl. minority) | 8,471 | 8,704 | 8,807 | 8,385 | 7,631 |
| Retained earnings | 6,449 | 6,615 | 6,553 | 6,659 | 6,349 |
| Minority interest | 330 | 507 | 442 | 71.7 | 15.6 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12,801 | 12,256 | 11,823 | 12,046 | 11,533 | 10,268 | 9,997 | 10,383 | 10,306 | 10,674 | 10,586 | 10,101 |
| Current assets | 7,875 | 8,003 | 7,700 | 7,980 | 7,471 | 5,728 | 5,388 | 5,120 | 4,979 | 5,266 | 5,175 | 5,243 |
| Cash and equivalents | 1,204 | 1,437 | 1,596 | 1,964 | 2,082 | 2,398 | 2,988 | 2,346 | 1,776 | 2,510 | 3,049 | 2,367 |
| Short-term investments | 7.9 | 17.9 | 46.2 | — | 46.2 | 118 | — | — | — | — | — | — |
| Receivables | — | 771 | 653 | 595 | 674 | 263 | 148 | 111 | 100 | 128 | 170 | 105 |
| Inventory | 5,140 | 4,799 | 4,528 | 4,218 | 3,427 | 1,993 | 1,393 | 1,202 | 1,174 | 1,140 | 1,103 | 1,176 |
| Net property, plant and equipment | 1,261 | 1,220 | 1,208 | 1,141 | 1,130 | 1,024 | 990 | 1,014 | 1,016 | 1,079 | 566 | 348 |
| Goodwill | 310 | 214 | 214 | 214 | 214 | 214 | 214 | 214 | 214 | 214 | 214 | 214 |
| Other intangible assets | 133 | 89.7 | 87.5 | 88.3 | 91.6 | 94.7 | 97.3 | 101 | 104 | 108 | 110 | 116 |
| Long-term investments | 89.3 | 2,053 | 2,053 | 2,051 | 2,038 | 2,784 | 2,892 | 3,241 | 3,306 | 3,321 | 3,354 | 3,287 |
| Current liabilities | 3,028 | 3,193 | 2,721 | 2,906 | 2,366 | 1,028 | 744 | 743 | 695 | 768 | 1,009 | 765 |
| Accounts payable | 1,090 | 1,086 | 994 | 1,539 | 1,455 | 495 | 269 | 224 | 233 | 276 | 300 | 141 |
| Long-term debt | 439 | 390 | 361 | 342 | 304 | 313 | 252 | 252 | 268 | 278 | 245 | 260 |
| Total debt | 2,038 | 1,828 | 1,706 | — | 854 | 531 | — | — | — | — | — | — |
| Total liabilities | 4,100 | 3,828 | 3,352 | 3,460 | 2,904 | 1,593 | 1,293 | 1,514 | 1,477 | 1,563 | 1,779 | 1,581 |
| Total equity (incl. minority) | 8,701 | 8,429 | 8,471 | 8,586 | 8,629 | 8,675 | 8,704 | 8,870 | 8,829 | 9,111 | 8,807 | 8,519 |
| Retained earnings | 5,564 | 6,433 | 6,449 | 6,595 | 6,617 | 6,595 | 6,615 | 6,476 | 6,437 | 6,558 | 6,553 | 6,566 |
| Minority interest | 291 | 298 | 330 | 435 | 452 | 491 | 507 | 546 | 569 | 590 | 442 | 79.0 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -4,131 | -217 | -241 | -671 | 359 |
| Depreciation and amortization | 87.4 | 72.7 | 43.0 | 39.0 | 31.2 |
| Capital expenditure | -291 | -91.3 | -694 | -175 | -108 |
| Investing cash flow | 1,295 | 326 | -40.3 | 356 | 173 |
| Financing cash flow | 896 | -165 | 583 | 247 | 178 |
| Dividends paid | -72.4 | -61.7 | -143 | -117 | -97.3 |
| Share repurchases | -93.7 | -250 | — | — | — |
| Debt issued | 1,696 | 218 | 679 | 259 | 88.5 |
| Debt repaid | -634 | -463 | -292 | -119 | -22.0 |
| Effect of exchange rates | -1.6 | 0.4 | -0.5 | 1.0 | -0.2 |
| Net change in cash | -1,942 | -54.8 | 302 | -66.7 | 710 |
| Free cash flow | -4,422 | -308 | -934 | -845 | 251 |
| Levered free cash flow | -3,867 | -381 | -621 | -312 | 733 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | 32.0 | -193 | -644 | -1,741 | -1,553 | -176 | 19.5 | -4.9 | -55.0 | -73.1 | -134 |
| Depreciation and amortization | — | — | 87.4 | -41.1 | 41.1 | — | 72.7 | -30.9 | 30.9 | — | 43.0 | -19.9 |
| Capital expenditure | -47.5 | -49.4 | -80.9 | -30.2 | -97.4 | -82.2 | -17.9 | -15.4 | -8.3 | -49.6 | -289 | -24.2 |
| Investing cash flow | -137 | -128 | -57.3 | 86.0 | 648 | 618 | 870 | 631 | -475 | -701 | 424 | -709 |
| Financing cash flow | 819 | 159 | 182 | 418 | 209 | 86.6 | -52.8 | -77.4 | -252 | 217 | 336 | -38.0 |
| Dividends paid | -18.5 | -9.2 | -1.7 | -54.0 | -13.2 | -3.5 | -7.0 | -49.1 | -3.0 | -2.6 | -5.1 | -132 |
| Share repurchases | — | — | -93.7 | — | -70.7 | — | -250 | — | -250 | — | — | — |
| Debt issued | 1,037 | 431 | 410 | 689 | 476 | 120 | 30.0 | 73.0 | 33.3 | 81.8 | 135 | 169 |
| Debt repaid | -260 | -493 | -241 | -189 | -176 | -27.3 | -77.2 | -90.6 | -112 | -183 | -83.2 | -63.5 |
| Effect of exchange rates | 1.2 | -0.5 | -1.2 | -0.3 | -1.4 | 1.3 | 0.7 | -0.5 | 0.1 | 0.1 | -1.4 | -0.2 |
| Net change in cash | -502 | 62.4 | -69.5 | -140 | -885 | -847 | 642 | 573 | -731 | -539 | 685 | -881 |
| Free cash flow | -1,232 | -17.4 | -274 | -674 | -1,838 | -1,635 | -194 | 4.1 | -13.3 | -105 | -362 | -158 |
| Levered free cash flow | — | -219 | -677 | -661 | -1,163 | -1,363 | -158 | -146 | 28.1 | -108 | 41.7 | -407 |
Financial statements of similar companies
Companies in the group: same industry, similar size
